Emily Olsen
The mobile platform allows users to access pharmacy services and make appointments, search for drug options and get manufacturer coupons.
The device will sell for $69.99 and ship in December.
The company said its valuation is now $1.4 billion.
The latest round follows a $14 million Series B raise from 2019.
The company said the Series B brings its total raise to $20 million.
The POGO system was first cleared by the FDA in 2016.
The company said it’s app analyzes weekly urine tests to provide nutrition and lifestyle guidance.
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
The company was founded last year and has raised $2.2 million in seed funding.
The companies said their collaboration will improve access to care, particularly for those who would benefit from additional in-person care.